Institutional investors purchased a net $930.4 thousand shares of INO during the quarter ended December 2016, and now own 27.79% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VANGUARD INVESTMENTS AUSTRALIA L... Bought 3.5 Thousand shares of Inovio Pharmaceuticals In...
CREDIT SUISSE AG Bought 1.9 Thousand shares of Inovio Pharmaceuticals In...